Runs a single-cell functional test that exposes a patient's own tumor cells to a library of treatments to see which ones work. Targets hematological malignancies and solid tumors.
One email, every morning
THE MORNING BRIEF
New clearances, funding rounds and regulatory moves for device founders, and every new how-to guide and template as it lands. No noise, no login.
✓
You're in. The next morning brief lands in your inbox.
No Spam. Unsubscribe anytime.